Obesity Rx: How to Use New Medications in Clinic Medscape InDiscussion: Obesity

Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982636). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment
Drugs for Treating Obesity https://pubmed.ncbi.nlm.nih.gov/34783910/
Control-Theory Models of Body-weight Regulation and Body-weight-regulatory Appetite https://pubmed.ncbi.nlm.nih.gov/31494154/
Obesogenic Environments: Current Evidence of the Built and Food Environments https://pubmed.ncbi.nlm.nih.gov/28449616/
FDA-approved Pharmacotherapy for Weight Loss Over the Last Decade https://pubmed.ncbi.nlm.nih.gov/36277516/
Tirzepatide https://pubmed.ncbi.nlm.nih.gov/36251836/
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics https://pubmed.ncbi.nlm.nih.gov/36706749/
Once-Weekly Semaglutide in Adults With Overweight or Obesity https://pubmed.ncbi.nlm.nih.gov/34192447/
Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/
Bariatric Surgery https://emedicine.medscape.com/article/197081-overview
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
Body Mass Index https://medlineplus.gov/ency/article/007196.htm
Descriptive Analysis of Reported Adverse Events Associated With Anti-obesity Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2020 https://pubmed.ncbi.nlm.nih.gov/34564826/
Antiobesity Drug Therapy: An Individualized and Comprehensive Approach https://pubmed.ncbi.nlm.nih.gov/34341028/
Barriers and Solutions for Prescribing Obesity Pharmacotherapy https://pubmed.ncbi.nlm.nih.gov/32418592/
Addressing Insurance-related Barriers to Novel Antiobesity Medications: Lessons to Be Learned From Bariatric Surgery https://pubmed.ncbi.nlm.nih.gov/36190393/
Certifying Physicians in the Treatment of Obesity https://www.abom.org/